by Jack Phillips at The Epoch Times
Pfizer recently stated that data from Israel and the United States suggests that its COVID-19 vaccine efficacy drops over time and claimed that booster doses are effective at dealing with new virus variants.
Federal health officials announced two weeks ago a target date of Sept. 20 to try to roll out booster shots for the general public, although a recent study from several top scientists at the World Health Organization (WHO) and Food and Drug Administration (FDA) found that the general population doesn’t need a booster dose.
“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier in the vaccination campaigns compared to those who have been vaccinated more recently,” Pfizer stated during its presentation this week, which was posted on the FDA website.
And the evidence from the studies indicates that the “observed decrease of vaccine effectiveness against COVID-19 infections is primarily due to waning of vaccine immune responses over time rather than a result of the Delta variant escaping vaccine protection,” according to Pfizer.
Based on its data, Pfizer claimed that booster doses should be given to all people aged 16 and older six months after they’ve received their second dose of the mRNA vaccine.
The pharmaceutical giant, which partnered with BioNTech to…
Continue Reading